The Global RNA Interference Technology Market is expected to grow from USD 13,412.13 Million in 2018 to USD 43,756.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 18.40% ...

Scientists hope RNA interference, which exploits a natural phenomenon, will prove easier to deliver. RNA interference research is rapidly evolving, and the phenomenon remains little-understood.

RNA interference (RNAi) is a widely applied method, offering a fast and easy system to study gene functions. In this talk, we will take a look at the technology of endoribonuclease-prepared siRNAs ...

The agreement provides research funding for Replicate and up to $550M in payments to develop medicines for diseases including ...

Science X Science News Wire : Innovative screening method uses RNA interference technology to identify 'lethal' and 'rescuer' genes -- a press release is provided to you ìas isî with little or no ...

San Diego startup DTx Pharma, which is developing technology for delivering RNA-based therapies to hard-to-treat diseases, has been acquired by drug giant Novartis for $500 million. Founded in ...

Hongene to supply exNA oligonucleotide technology under new licensing deal SINGAPORE (August 26th, 2025) – Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) ...

By marshaling the naturally occurring phenomenon of RNA interference, scientists are developing new ways to silence errant gene expression involved in illnesses.

The firm's antisense oligonucleotide, or ASO, technology faces strong competition from RNA interference technology emerging from Alnylam, Arrowhead, and Dicerna, as well as gene editing and gene ...

The firm's antisense oligonucleotide, or ASO, technology faces strong competition from RNA interference technology emerging from Alnylam, Arrowhead, and Dicerna, as well as gene editing and gene ...